Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Relaxin in Decompensated CHF
NCT00406575Phase 2Terminated
- Start
- Nov 2006
- Primary completion
- Jan 2007
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of serelaxin in congestive heart failure (CHF). Started Nov 2006; status: terminated.
02
Drugs
serelaxin
03
Conditions
congestive heart failure (CHF)
Beyond the preview
Go deeper on NCT00406575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406575.